Overview Fundamentals API Earnings EOD API Sample Code Pricing

Intech Biopharm Ltd (6461 TWO) stock market data APIs

NT$28.65 -0.1(-0.3%) as of October 22, 2024
Price chart is built with Anychart

Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.

Intech Biopharm Ltd Financial Data Overview

28.75
28.65
-
28.95
28.55
23.6-34.6
3 950 M
137 M
32 278 K
-0.6957
0.319
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '6461',
Type: 'Common Stock',
Name: 'Intech Biopharm Ltd',
Exchange: 'TWO',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: 'TW0006461007',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Intech Biopharm Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 32 278 K
  • EBITDA -249 828 992
  • Earnings Per Share -2.71
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Intech Biopharm Ltd Earnings via APIs

  • Latest Release 2023-05-31
  • EPS/Forecast NaN

Get Intech Biopharm Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com